CLS Holdings USA (XCNQ:CLSH) EBIT per Share : C$-0.10 (TTM As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CLS Holdings USA EBIT per Share?

CLS Holdings USA's EBIT per Share for the three months ended in Feb. 2024 was C$-0.04. Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.10.

During the past 3 years, the average EBIT per Share Growth Rate was 38.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 51.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for CLS Holdings USA's EBIT per Share or its related term are showing as below:

XCNQ:CLSH' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -214.1 Med: 34 Max: 68.8
Current: 38.2

During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of CLS Holdings USA was 68.80% per year. The lowest was -214.10% per year. And the median was 34.00% per year.

XCNQ:CLSH's 3-Year EBIT Growth Rate is ranked better than
83.76% of 850 companies
in the Drug Manufacturers industry
Industry Median: 7.95 vs XCNQ:CLSH: 38.20

CLS Holdings USA's EBIT for the three months ended in Feb. 2024 was C$-4.96 Mil.

CLS Holdings USA EBIT per Share Historical Data

The historical data trend for CLS Holdings USA's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA EBIT per Share Chart

CLS Holdings USA Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

EBIT per Share

Get a 7-Day Free Trial

-1.21

-1.23

-0.37

0.07

-0.22

CLS Holdings USA Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EBIT per Share	Get a 7-Day Free Trial															-	-0.06	0.01	-0.01	-0.04

CLS Holdings USA EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

CLS Holdings USA's EBIT per Share for the fiscal year that ended in May. 2023 is calculated as

	EBIT per Share		(A: May. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-13.459	/	60.655
=	-0.22

CLS Holdings USA's EBIT per Share for the quarter that ended in Feb. 2024 is calculated as

	EBIT per Share		(Q: Feb. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-4.96	/	118.630
=	-0.04

EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.10

CLS Holdings USA (XCNQ:CLSH) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

CLS Holdings USA EBIT per Share Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

CLS Holdings USA (XCNQ:CLSH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (XCNQ:CLSH) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

CLSH:USA

Address

1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102

Website

https://www.clsholdingsinc.com

CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.